Verona Pharma plc (VRNA)

Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)

106.91

+0.12 (0.11%)

Inactive · Last trade price on Oct 6, 2025

Verona Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Oct '25 Oct 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	9,215	3,800	1,709	2,133	444	405	Upgrade
Market Cap Growth	278.24%	122.40%	-19.89%	380.79%	9.47%	435.09%	Upgrade
Enterprise Value	9,021	3,587	1,472	1,907	283	205	Upgrade
Last Close Price	106.91	46.44	19.88	26.13	6.72	7.00	Upgrade
PS Ratio	40.39	89.89	-	4657.40	11.09	-	Upgrade
PB Ratio	33.04	18.58	6.85	9.26	3.00	2.19	Upgrade
P/TBV Ratio	33.18	18.63	6.87	9.28	3.01	2.20	Upgrade
EV/Sales Ratio	40.70	84.83	-	4164.23	7.09	-	Upgrade
Debt / Equity Ratio	0.88	1.12	0.21	0.05	0.04	0.03	Upgrade
Asset Turnover	0.44	0.11	-	0.00	0.21	-	Upgrade
Quick Ratio	10.25	10.24	32.53	12.46	4.91	13.82	Upgrade
Current Ratio	10.71	10.63	33.33	12.77	5.09	14.26	Upgrade
Return on Equity (ROE)	-36.36%	-76.42%	-22.67%	-36.30%	-33.39%	-57.25%	Upgrade
Return on Assets (ROA)	-6.68%	-24.13%	-14.64%	-18.53%	-18.45%	-31.68%	Upgrade
Return on Capital (ROIC)	-8.28%	-25.72%	-15.34%	-20.93%	-20.92%	-35.14%	Upgrade
Earnings Yield	-0.88%	-4.56%	-3.18%	-3.22%	-12.53%	-16.07%	Upgrade
FCF Yield	-0.80%	-3.23%	-2.94%	-2.81%	-7.50%	-11.14%	Upgrade
Buyback Yield / Dilution	-4.09%	-2.86%	-19.86%	-11.81%	-79.97%	-149.64%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q